0 items

in your cart

  • Search for Medications
  • Viewcart | Checkout
  • Manage Account
  • Click-to-Call  

Prescription Drug Search

Strengths available for Jakafi:

Jakafi 5mg
Jakafi 15mg
Jakafi 20mg

Search for a drug:


Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about SaveRxCanada.to

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Jakafi:

  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Aruba
  • Bahrain
  • Bangladesh
  • Belgium
  • Bermuda
  • Bosnia and Herzegovina
  • Colombia
  • Costa Rica
  • Croatia
  • Denmark
  • European Union
  • Fiji
  • Germany
  • Gibraltar
  • Greece
  • Grenada
  • Guatemala
  • India
  • Korea, South
  • Lebanon
  • Lithuania
  • Luxembourg
  • Moldova, Republic of
  • Philippines
  • Poland
  • Saint Lucia
  • Singapore
  • Slovenia
  • South Africa
  • Spain
  • Sri Lanka
  • Taiwan
  • United Arab Emirates
  • United Kingdom, UK
  • United States, US
  • Uruguay
  • Venezuela
View All Countries

Latest news releases on Jakafi:

Jakafi - Polycythemia Vera (PV) & Myelofibrosis (MF ...

Jakafi is a treatment for patients with intermediate or high-risk myelofibrosis and patients with polycythemia vera who did not benefit from or could not tolerate hydroxyurea.

Ruxolitinib - Wikipedia

Ruxolitinib (trade names Jakafi / ˈ dʒ æ k ə f aɪ / JAK-ə-fye and Jakavi) is a drug for the treatment of intermediate or high-risk myelofibrosis, a type of myeloproliferative disorder that affects the bone marrow, and for polycythemia vera (PCV) when there has been an inadequate response to or intolerance of hydroxyurea.

Jakafi - FDA prescribing information, side effects and uses

Jakafi official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.

Polycythemia Vera & Myelofibrosis Treatment | Jakafi ...

Jakafi (ruxolitinib) is an FDA-approved treatment for patients with intermediate or high-risk myelofibrosis and for patients with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea.

Jakafi Oral : Uses, Side Effects, Interactions, Pictures ...

Find patient medical information for Jakafi Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Jakafi (Ruxolitinib): Side Effects, Interactions, Warning ...

Learn about Jakafi (Ruxolitinib) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.

Ruxolitinib (By mouth) - National Library of Medicine ...

Ruxolitinib (By mouth) ... Antineoplastic Agent (About this - PubMed Health) Uses Uses of This Medicine. ... Jakafi. There may be other ...

Jakafi: Uses, Dosage, Side Effects & Warnings - Drugs.com

Jakafi (ruxolitinib) is used to treat myelofibrosis, a bone marrow disorder that affects your body's ability to produce blood cells. Includes Jakafi side effects, interactions and indications.

Jakafi Prices and Jakafi Coupons - GoodRx

Compare prices and print coupons for Jakafi and other Myelofibrosis drugs at CVS, Walgreens, and other pharmacies. Prices start at $12162.90

European Medicines Agency - Find medicine - Jakavi

European Union agency responsible for the protection of public and animal health through the scientific evaluation and supervision of medicines.

Customer Service
1-866-799-3435 | Contact Form
Copyright © 2018 SaveRxCanada.to All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK